Skip to main content
Premium Trial:

Request an Annual Quote

Adaptive Biotechnologies: Mark Adams, Julie Rubenstein

Adaptive Biotechnologies has informed its chief operating officer Mark Adams that his service is being terminated by May 2023. His duties will be absorbed by the company's current president Julie Rubinstein, according to the firm's filing with the US Securities and Exchange Commission.